facebook  linkedin xpix

Diary Dates
Save the date for important iCMLf meetings and programs
calendar

Become a member

Become an iCMLf member - help shape our future
member-button

Please donate

Support our activities
by donating
Donate here

Supporters

We thank all our supporters and partners

supporter-lay2

If you are not a member, please click on "Register". If you have forgotten your password, please click on "Forgot login?" below.

iCMLf Diagnosis and Testing Program -
Apply now for 2017 grants

'This is the first CML-related molecular assay in Ethiopia. We are extremely glad to know the molecular status of our patients. No more blind treatment of CML patients in Ethiopia'
(Dr Gebremedhin, Ethiopia)

The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.

Over five years the iCMLf have awarded 42 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2017 the Foundation will again offer 10 grants with funding of up to $10,000.

Applications will close on the 30th of June 2017. Proposals are welcome to melissa@cml-foundation.org or read more for further information on how to apply.

Read more ...

Winners of the 2015 Diagnosis & Testing grants

Building on the success of the program in previous years, again in 2015 the iCMLf offers seed funding to hematology institutions in emerging economic regions to build local capacity for CML testing. From the applications this year the iCMLf Directors have selected 10 projects for seed funding to build CML capacity in the emerging regions. Countries include; Bolivia, Honduras, India, Indonesia, Kenya, Macedonia, Niger and Nigeria.

The successful centres are the following:

  1. All India Institute of Medical Sciences, New Delhi (India)
  2. National Hospital of Zinder (Niger)
  3. Instituto Oncológico del Oriente de Bolivia (Bolivia)
  4. Centro de Cáncer Emma Romero de Callejas (Honduras)
  5. Ulin General Hospital, Banjarsamin, South Kalimantan (Indonesia)
  6. University of Nairobi/Kenyatta National Hospital, Nairobi (Kenya)
  7. University Clinic for Hematology, Faculty of Medicine, Skopje (Macedonia)
  8. National Hospital Abuja, Abuja (Nigeria)
  9. Prince Aly Khan Hospital, Mumbai (India)
  10. Obafemi Awolowo University, Ile Ife (Nigeria)

Read more ...

About the Diagnosis and Testing program

The iCMLf Diagnosis and Testing Program launched in 2011 offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in developing countries where this is limited or not currently available. Through small grants and partnerships with CML centres of excellence the Diagnosis and Testing Program plans to enable centres in emerging regions to increase their local capacity to diagnose and conduct long-term monitoring of their CML patients.

Read more ...

How does the program work?

The aim of the iCMLf Diagnosis & Testing Program is to build local capacity for CML diagnostics. In this way we can improve patient outcomes. Diagnosis & Testing grants are available to physicians, scientists and hematology laboratory staff working in a hospital or research institution. Building local capacity and resource sustainability are important criteria for this iCMLf funding.

The emphasis will be on finding partners in emerging regions who can implement a local solution and leverage local support on top of the limited iCMLf funds. The iCMLf will provide seeding grants to assist in funding tests, reagents, sample transport and the logistics to conduct the program.

Read more ...